These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 9097003)

  • 1. Are young age and insulin treatment enough to diagnose IDDM?
    Maislos M; Weitzman S
    Diabetes Care; 1997 Apr; 20(4):675-6. PubMed ID: 9097003
    [No Abstract]   [Full Text] [Related]  

  • 2. Clinical heterogeneity of insulin dependent diabetes mellitus in Korea.
    Lee KU; Kim SW; Park JY; Ko KS; Rhee BD; Min HK
    Diabetes Res Clin Pract; 1995 Feb; 27(2):159-62. PubMed ID: 7607055
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [C-peptide measurement in the classification of diabetes mellitus and in the assessment of requirements for insulin treatment].
    Gjessing HJ
    Ugeskr Laeger; 1990 Feb; 152(9):588-93. PubMed ID: 2408222
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of C-peptide in the classification of diabetes mellitus.
    Wright-Pascoe R; Mills J; Choo-Kang E; Morrison EY
    West Indian Med J; 2000 Jun; 49(2):138-42. PubMed ID: 10948853
    [TBL] [Abstract][Full Text] [Related]  

  • 5. C-peptide in diabetes mellitus treated with insulin. A 3-year epidemiological study on the island of Falster, Denmark.
    Nielsen NV; Tronier B
    Diabetes Res; 1986 Nov; 3(9):475-8. PubMed ID: 3549123
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence of IDDM in adults in the community.
    Maislos M; Weitzman S
    Diabetes Care; 1995 Jun; 18(6):885-6. PubMed ID: 7555523
    [No Abstract]   [Full Text] [Related]  

  • 7. Phases of diabetes in children and adolescents.
    Couper J; Donaghue KC
    Pediatr Diabetes; 2009 Sep; 10 Suppl 12():13-6. PubMed ID: 19754614
    [No Abstract]   [Full Text] [Related]  

  • 8. Glucagon-induced plasma C-peptide response in diabetic patients. Influence of body weight and relationship to insulin requirement.
    Scheen AJ; Castillo MJ; Lefèbvre PJ
    Diabetes Metab; 1996 Dec; 22(6):455-8. PubMed ID: 8985655
    [No Abstract]   [Full Text] [Related]  

  • 9. Fasting C-peptide and Related Parameters Characterizing Insulin Secretory Capacity for Correctly Classifying Diabetes Type and for Predicting Insulin Requirement in Patients with Type 2 Diabetes.
    Becht FS; Walther K; Martin E; Nauck MA
    Exp Clin Endocrinol Diabetes; 2016 Mar; 124(3):148-56. PubMed ID: 26824281
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Re: A comparison of classification schemes for ketosis-prone diabetes.
    Nalini R; Maldonado M; Balasubramanyam A
    Nat Clin Pract Endocrinol Metab; 2007 Dec; 3(12):E1. PubMed ID: 18026157
    [No Abstract]   [Full Text] [Related]  

  • 11. Misunderstanding in the classification of diabetes mellitus. What's in a name?
    Elks ML; Sawyer JW
    West J Med; 1993 Jul; 159(1):44-9. PubMed ID: 8351904
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antibodies to glutamic acid decarboxylase reveal latent autoimmune diabetes mellitus in adults with a non-insulin-dependent onset of disease.
    Tuomi T; Groop LC; Zimmet PZ; Rowley MJ; Knowles W; Mackay IR
    Diabetes; 1993 Feb; 42(2):359-62. PubMed ID: 8425674
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diurnal variation of blood ketone bodies in insulin-dependent diabetes mellitus and noninsulin-dependent diabetes mellitus patients: the relationship to serum C-peptide immunoreactivity and free insulin.
    Ubukata E
    Ann Nutr Metab; 1990; 34(6):333-42. PubMed ID: 2076025
    [TBL] [Abstract][Full Text] [Related]  

  • 14. C-peptide profiles in young diabetics.
    Nihalani KD; Varthakavi PK; Patel KL; Merchant PC
    J Assoc Physicians India; 1993 Jun; 41(6):345-9. PubMed ID: 8005969
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Classification of newly diagnosed diabetic patients as insulin-requiring or non-insulin-requiring based on clinical and biochemical variables.
    Hother-Nielsen O; Faber O; Sørensen NS; Beck-Nielsen H
    Diabetes Care; 1988; 11(7):531-7. PubMed ID: 3203569
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Random C peptide measurement in adults with clinical diagnosis of type 1 diabetes].
    Rodacki M; Zajdenverg L; Milech A; Oliveira JE
    Rev Assoc Med Bras (1992); 2008; 54(3):238-41. PubMed ID: 18604402
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of insulin on body composition in patients with insulin-dependent and non-insulin-dependent diabetes.
    Sinha A; Formica C; Tsalamandris C; Panagiotopoulos S; Hendrich E; DeLuise M; Seeman E; Jerums G
    Diabet Med; 1996 Jan; 13(1):40-6. PubMed ID: 8741811
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Both insulin sensitivity and insulin clearance in children and young adults with type I (insulin-dependent) diabetes vary with growth hormone concentrations and with age.
    Acerini CL; Cheetham TD; Edge JA; Dunger DB
    Diabetologia; 2000 Jan; 43(1):61-8. PubMed ID: 10663217
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Subcutaneous glucagon-like peptide I combined with insulin normalizes postcibal glycemic excursions in IDDM.
    Dupré J; Behme MT; Hramiak IM; McDonald TJ
    Diabetes Care; 1997 Mar; 20(3):381-4. PubMed ID: 9051391
    [No Abstract]   [Full Text] [Related]  

  • 20. Determinants of clinical remission in recent-onset IDDM.
    Hramiak IM; Dupre J; Finegood DT
    Diabetes Care; 1993 Jan; 16(1):125-32. PubMed ID: 8422766
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.